H. Cortés-Funes - Concepedia

Author

H. Cortés-Funes

Also Known As

Cortés-Funes, Hernán, H CORTESFUNES, H Cortes-Funes, H Cortés-Funes, H Cortés-Funes, H. Cortes-Funes, H. Cortès-Funes, H. Cortés-Funes, H. Cortés-funes, H. Córtes-Funes

278

Publications

14.2K

Citations

H-Index

121

Concepts

All Affiliations

Hospital Universitario 12 De Octubre Research Institute Hospital 12 de Octubre Hospital Clínico Universitario de Valencia Institut Català d'Oncologia Hospital Clínico San Carlos

About

H. Cortés-Funes is an author at Hospital Universitario 12 De Octubre specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	66	3.8K
2	Health Sciences	15	18	1.1K
3	Nursing	2	2	65
4	Public Health	2	2	52
5	Language Studies	1	1	22

H. Cortés-Funes

114

Publications

12.5K

Citations

H-Index

Page 1

	Year	Citations
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer Aimery de Gramont, Arié Figer, Michel Seymour, Journal of Clinical Oncology	2000	3.8K
International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers GM Mead, SP Stenning, Penny A. Cook, University of Groningen research database (University of Groningen / Centre for Information Technology)	1997	1K
Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck José Baselga, José Trigo, Jean Bourhis, Journal of Clinical Oncology	2005	491
Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer Ricardo Hitt, Antonio López–Pousa, Javier Martínez‐Trufero, Journal of Clinical Oncology	2005	451
A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer Ricardo Hitt, Juan J. Grau, Antonio López–Pousa, Annals of Oncology Neck CancerNeoadjuvant TherapyRadiation TherapyMedicineUnresectable Head	2013	345
Burdens and Benefits of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil and Tamoxifen for Elderly Patients With Breast Cancer: The International Breast Cancer Study Group Trial VII Diana Crivellari, Marco Bonetti, Monica Castiglione‐Gertsch, Journal of Clinical Oncology	2000	294
Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II study U. Gatzemeier, Frances A. Shepherd, Thierry Le Chevalier, European Journal of Cancer MedicinePharmacologyPhase Ii StudyPharmacotherapyAnti-cancer Agent	1996	242
Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients H. Cortés-Funes, Carlos Gegúndez Gómez, Rafael Rosell, Annals of Oncology MedicinePathologyBronchial NeoplasmCancer TreatmentCancer Genetics	2005	231
Oxaliplatin as single agent in previously untreated colorectal carcinoma patients: A phase II multicentric study Eduardo Díaz‐Rubio, Javier Sastre, Alberto Zaniboni, Annals of Oncology Gastrointestinal OncologySingle AgentMedicineCancer ManagementPharmacology	1998	227
Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck Ricardo Hitt, H. Cortés-Funes, Juan J. Grau, Annals of Oncology MedicinePathologyPhase Ii StudyWeekly PaclitaxelFirst-line Treatment	2011	220

Page 1